Drew D Ritter, MD | |
3676 Parker Blvd, Suite 390, Pueblo, CO 81008-2210 | |
(719) 595-7780 | |
(719) 595-7789 |
Full Name | Drew D Ritter |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 41 Years |
Location | 3676 Parker Blvd, Pueblo, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528038890 | NPI | - | NPPES |
01264241 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | CO26424 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Parkview Medical Center, Inc | Pueblo, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Parkview Ancillary Services Corporation | 4385722511 | 267 |
News Archive
Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV.
The U.S. Food and Drug Administration (FDA) has chosen a family doctor to lead its women's health office.
A research team headed by scientists at University of California San Diego School of Medicine and the Ludwig Institute for Cancer Research at UC San Diego has identified an enzyme involved in remodeling the plasma membrane of multiple cancer cell types that is critical to both survival of tumors and their uncontrolled growth.
Repligen Corporation announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Wednesday, December 9th, 2009 at 8:30 a.m. EST, to discuss results of its Phase 3 clinical trial of RG1068 in MRI imaging of the pancreas.
› Verified 7 days ago
Entity Name | Parkview Ancillary Services Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982878765 PECOS PAC ID: 4385722511 Enrollment ID: O20080429000248 |
News Archive
Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV.
The U.S. Food and Drug Administration (FDA) has chosen a family doctor to lead its women's health office.
A research team headed by scientists at University of California San Diego School of Medicine and the Ludwig Institute for Cancer Research at UC San Diego has identified an enzyme involved in remodeling the plasma membrane of multiple cancer cell types that is critical to both survival of tumors and their uncontrolled growth.
Repligen Corporation announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Wednesday, December 9th, 2009 at 8:30 a.m. EST, to discuss results of its Phase 3 clinical trial of RG1068 in MRI imaging of the pancreas.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Drew D Ritter, MD 3676 Parker Blvd, Suite 390, Pueblo, CO 81008-2210 Ph: (719) 595-7780 | Drew D Ritter, MD 3676 Parker Blvd, Suite 390, Pueblo, CO 81008-2210 Ph: (719) 595-7780 |
News Archive
Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV.
The U.S. Food and Drug Administration (FDA) has chosen a family doctor to lead its women's health office.
A research team headed by scientists at University of California San Diego School of Medicine and the Ludwig Institute for Cancer Research at UC San Diego has identified an enzyme involved in remodeling the plasma membrane of multiple cancer cell types that is critical to both survival of tumors and their uncontrolled growth.
Repligen Corporation announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Wednesday, December 9th, 2009 at 8:30 a.m. EST, to discuss results of its Phase 3 clinical trial of RG1068 in MRI imaging of the pancreas.
› Verified 7 days ago
Shawn Jett Nakamura, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4112 Outlook Blvd Ste 37, Pueblo, CO 81008 Phone: 719-562-6254 Fax: 719-562-6255 | |
Shane Rothermel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3676 Parker Blvd Ste 390, Pueblo, CO 81008 Phone: 719-595-7780 Fax: 719-595-7789 | |
Lucas Raymond King, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3676 Parker Blvd., Ste 310, Pueblo, CO 81008 Phone: 719-595-7780 Fax: 719-595-7789 | |
Roger W Davis, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3676 Parker Blvd, Suite 230, Pueblo, CO 81008 Phone: 719-553-2206 Fax: 719-553-2226 | |
Dr. Alex Anthony Romero, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4112 Outlook Blvd, Suite 37, Pueblo, CO 81008 Phone: 719-562-6254 Fax: 719-562-6255 | |
Jennifer Fitzpatrick, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3676 Parker Blvd, Suite 390, Pueblo, CO 81008 Phone: 719-595-7780 Fax: 719-595-7789 | |
Lance R. Farnworth, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1919 W Us Highway 50, Pueblo, CO 81008 Phone: 719-253-7102 Fax: 719-253-7114 |